Alzheimer’s Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer’s Clinical Trial Consortium Sites | Zendy

Elizabeth K. Rhodus | Zendy; Paul Aisen | Zendy; J D Grill | Zendy; D.M. Rentz | Zendy; R.C. Petersen | Zendy; R A Sperling | Zendy; S.P. Salloway | Zendy; D. Pierce | Zendy; Rema Raman | Zendy

Open Access

Alzheimer’s Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer’s Clinical Trial Consortium Sites

Author(s) -

Elizabeth K. Rhodus,

Paul Aisen,

J D Grill,

D.M. Rentz,

R.C. Petersen,

R A Sperling,

S.P. Salloway,

D. Pierce,

Rema Raman

Publication year - 2022

Publication title -

the journal of prevention of alzheimer s disease

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.733

H-Index - 13

eISSN - 2426-0266

pISSN - 2274-5807

DOI - 10.14283/jpad.2022.79

Subject(s) - pandemic , covid-19 , clinical trial , alzheimer's disease , disease , sample (material) , adaptation (eye) , medicine , psychology , gerontology , neuroscience , outbreak , virology , infectious disease (medical specialty) , chemistry , chromatography

The COVID-19 pandemic created challenges in clinical research operations that required immediate and lasting changes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research